Ranbaxy faces more enquiries on FDA ban (The Times of India)
A week after the US Food and Drug Administration (FDA) blocked over 30 drugs manufactured by Ranbaxy from its two facilities in India, all major geographies have sought details of the company's exports from India.

FDA Proposes Label Requirements For Refused Imported Foods (Medical News Today)
The U.S. Food and Drug Administration issued a proposed rule designed to reduce a practice known as "port shopping" which puts the safety of imported food at risk. "This system will make it more difficult for food importers to evade import controls after being denied admission into the United States," said Randall Lutter, Ph.D., deputy commissioner for policy.

FDA Clears MBL Bullous Pemphigoid ELISA Test (Medical News Today)
MBL International Corporation of Woburn, Massachusetts is announcing that the United States Food and Drug Administration, FDA, has cleared the BP180 and BP230 ELISA Kits for the detection of Bullous Pemphigoid (BP), the new kits have been CE marked as well. The new kits are seen as an advance in diagnosing Bullous Pemphigoid.